Membranes and barriers : targeted drug delivery

LDR 01721cam a2200469 a 4500
001 003079351
003 MiAaHDL
005 20160707000000.0
006 m d
007 cr bn ---auaua
007 cr unu
008 951026s1995 mdua b f100 0 eng d
010 ‡a95219833
035 ‡asdr-ucr.b25579733
035 ‡asdr-umn002475748
035 ‡asdr-pur923107
035 ‡a(GPO)99153023
037 ‡a017-024-01583-1 ‡bGPO
040 ‡aMoU ‡cDLC ‡dMMU ‡dMNE ‡dCUM ‡dGPO ‡dNLM ‡dOCL ‡dGPO ‡dDLC ‡dMvI
042 ‡alccopycat
049 9 9 ‡aRECLAMATION
060 1 0 ‡aQV 785 ‡bM533 1995
060 0 0 ‡aW1 ‡bNA486Q no.154 1995
074 ‡a0831-C-12 (online)
074 ‡a0831-C-12
086 0 ‡aHE 20.3965:154
098 ‡aHE203965154
098 ‡aElectronicbook
099 8 ‡aHE 20.3965:154
035 ‡a(OCoLC)33376119
245 0 0 ‡aMembranes and barriers : ‡btargeted drug delivery / ‡ceditor, Rao S. Rapaka.
260 ‡aRockville, MD : ‡bU.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Institute on Drug Abuse, Division of Preclinical Research, ‡c1995.
300 ‡aiv, 254 p. : ‡bill. ; ‡c24 cm.
490 0 ‡aNIH publication ; ‡vno. 95-3889
490 0 ‡aNIDA research monograph ; ‡v154
538 ‡aMode of access: Internet.
650 2 2 ‡aPharmaceutical Preparations ‡xadministration & dosage ‡vCongresses.
650 2 2 ‡aDrug Administration Routes ‡vCongresses.
650 2 2 ‡aDrug Carriers ‡vCongresses.
650 0 ‡aDrug targeting ‡vCongresses.
700 1 ‡aRapaka, Rao S.
710 2 ‡aNational Institute on Drug Abuse. ‡bDivision of Preclinical Research.
710 2 ‡aNational Institutes of Health (U.S.)
CID ‡a003079351
DAT 0 ‡a20040722095055.0 ‡b20160707000000.0
DAT 1 ‡a20160609090631.0 ‡b2023-12-30T18:46:46Z
DAT 2 ‡a2023-12-30T18:30:02Z
CAT ‡aSDR-UCR ‡dIII - MILLENIUM ‡lprepare.pl-004-006
FMT ‡aBK
HOL ‡0sdr-ucr.b25579733 ‡auc1 ‡bSDR ‡cUCR ‡puc1.31210012244925 ‡sUC ‡1.b25579733
974 ‡bUC ‡cUCR ‡d20231230 ‡sgoogle ‡uuc1.31210012244925 ‡y1995 ‡rpd ‡qbib ‡tUS fed doc
974 ‡bUMN ‡cUMN ‡d20230315 ‡sgoogle ‡uumn.31951d012538529 ‡y1995 ‡rpd ‡qbib ‡tUS fed doc
974 ‡bPUR ‡cPUR ‡d20240207 ‡sgoogle ‡upur1.32754065306056 ‡y1995 ‡rpd ‡qbib ‡tUS fed doc